Janssen pharma collaborates with Beth Israel Deaconess Medical Center for COVID-19 Vaccine Development Medical Dialogues Bureau14 March 2020 4:00 AM GMTJanssen's vaccine program will use the Janssen AdVac® and PER.C6® technologies that provide the ability to rapidly upscale production of an optimal...
HC relief to J&J: stays order directing co to pay Rs 230 crore on account of GST profiteering Medical Dialogues Bureau5 March 2020 7:15 AM GMTIt also said that prima facie the methodology used by NAPA to arrive at its finding of profiteering was 'flawed'.
